NDC Code(s) : 65649-651-02, 65649-651-03
Packager : Salix Pharmaceuticals, Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Ucerisbudesonide AEROSOL, FOAM | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
LABELER - Salix Pharmaceuticals, Inc.(793108036) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
DPT Laboratories Ltd. | 832224591 | MANUFACTURE(65649-651) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Carton Services, Incorporated | 928861723 | PACK(65649-651) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
ASM Aerosol Service AG | 480286111 | MANUFACTURE(65649-651) |
PRINCIPAL DISPLAY PANEL
NDC 65649-651-03
Rx only
UCERIS®
(budesonide) rectal foam
2mg/ actuation
For rectal administration only, as directed
by a physician. Shake well before using.
Each canister contains 14 metered doses.
Net weight 33.4 g per canister.
Salix
PHARMACEUTICALS